INVASIVE MAMMARY CARCINOMA
Clinical trials for INVASIVE MAMMARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE MAMMARY CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE MAMMARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Guided chemo trial aims to improve survival in tough breast cancer
Disease control Recruiting nowThis phase 2 trial is testing whether using gene tests (MammoPrint and BluePrint) to guide treatment can help people with a certain type of advanced breast cancer (HR+, HER2-negative) live longer. 64 participants will receive either chemotherapy (capecitabine) or hormone therapy …
Matched conditions: INVASIVE MAMMARY CARCINOMA
Phase: PHASE2 • Sponsor: Sonya Reid • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cancer immunotherapy may weaken bones, new study warns
Knowledge-focused Recruiting nowThis study looks at how immunotherapy drugs (anti-PD-1) affect bone strength in people being treated for cancer. Researchers will measure bone density and blood markers over a year in 25 patients. The goal is to understand if these treatments increase fracture risk, so doctors ca…
Matched conditions: INVASIVE MAMMARY CARCINOMA
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC